AAAAAA

   
Results: 1-16 |
Results: 16
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTICENTER STUDY OF PRAMIPEXOLE IN ADVANCED PARKINSONS-DISEASE
Authors: WERMUTH L
Citation: L. Wermuth, A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTICENTER STUDY OF PRAMIPEXOLE IN ADVANCED PARKINSONS-DISEASE, European journal of neurology, 5(3), 1998, pp. 235-242
APPLICABILITY AND VALIDITY OF THE MAJOR DEPRESSION INVENTORY IN PATIENTS WITH PARKINSONS-DISEASE
Authors: BECH P WERMUTH L
Citation: P. Bech et L. Wermuth, APPLICABILITY AND VALIDITY OF THE MAJOR DEPRESSION INVENTORY IN PATIENTS WITH PARKINSONS-DISEASE, Nordic journal of psychiatry, 52(4), 1998, pp. 305-309
DEPRESSION IN IDIOPATHIC PARKINSONS-DISEASE TREATED WITH CITALOPRAM -A PLACEBO-CONTROLLED TRIAL
Authors: WERMUTH L SORENSEN PS TIMM S CHRISTENSEN B UTZON NP BOAS J DUPONT E HANSEN E MAGNUSSEN I MIKKELSEN B WORMPETERSEN J LAURITZEN L BAYER L BECH P
Citation: L. Wermuth et al., DEPRESSION IN IDIOPATHIC PARKINSONS-DISEASE TREATED WITH CITALOPRAM -A PLACEBO-CONTROLLED TRIAL, Nordic journal of psychiatry, 52(2), 1998, pp. 163-169
TOLCAPONE ADDED TO LEVODOPA IN STABLE PARKINSONIAN-PATIENTS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
Authors: DUPONT E BURGUNDER JM FINDLEY LJ OLSSON JE DORFLINGER E BEISKE A FINDLEY L GODWINAUSTEN R HESS CW HORNE M LARSEN JP EKSTEDT B MIKKELSEN B PALHAGEN S PALM R TYSNES OB VANDERLINDEN C WERMUTH L
Citation: E. Dupont et al., TOLCAPONE ADDED TO LEVODOPA IN STABLE PARKINSONIAN-PATIENTS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Movement disorders, 12(6), 1997, pp. 928-934
THE EFFECTS OF EARLY SELEGILINE THERAPY ON LONG-TERM LEVODOPA TREATMENT AND PARKINSONIAN DISABILITY - AN INTERIM ANALYSIS OF A NORWEGIAN-DANISH 5-YEAR STUDY
Authors: LARSEN JP BOAS J AASLY J BOESEN F BOISEN E BORGMANN R DUPONT E ERDAL JE GILHUS NE HEINONEN E HUNSTAD N KILKKU O MAI J MELLGREN SI MIKKELSEN B NESSLER E SELSETH B VILMING S WERMUTH L WORMPETERSEN J OKSETER K
Citation: Jp. Larsen et al., THE EFFECTS OF EARLY SELEGILINE THERAPY ON LONG-TERM LEVODOPA TREATMENT AND PARKINSONIAN DISABILITY - AN INTERIM ANALYSIS OF A NORWEGIAN-DANISH 5-YEAR STUDY, Movement disorders, 12(2), 1997, pp. 175-182
HIGH PREVALENCE OF PARKINSONS-DISEASE IN THE FAROE ISLANDS
Authors: WERMUTH L JOENSEN P BUNGER N JEUNE B
Citation: L. Wermuth et al., HIGH PREVALENCE OF PARKINSONS-DISEASE IN THE FAROE ISLANDS, Neurology, 49(2), 1997, pp. 426-432
CATECHOL-O-METHYLTRANSFERASE INHIBITION WITH TOLCAPONE REDUCES THE WEARING OFF PHENOMENON AND LEVODOPA REQUIREMENTS IN FLUCTUATING PARKINSONIAN-PATIENTS
Authors: BAAS H BEISKE AG GHIKA J JACKSON M OERTEL WH POEWE W RANSMAYR G AUFF E VOLC D DUPONT E MIKKELSEN B WERMUTH L WOMMPETERSEN J BENECKE R EICHHOM T KOLBE H OERTEL W SCHIMRIGK K OLSSON JE PALHAGEN S BURGUNDER JM GHIKA A REGLI F STECK A MEDCALF P
Citation: H. Baas et al., CATECHOL-O-METHYLTRANSFERASE INHIBITION WITH TOLCAPONE REDUCES THE WEARING OFF PHENOMENON AND LEVODOPA REQUIREMENTS IN FLUCTUATING PARKINSONIAN-PATIENTS, Journal of Neurology, Neurosurgery and Psychiatry, 63(4), 1997, pp. 421-428
THE LEVODOPA DOSE-SPARING CAPACITY OF PERGOLIDE COMPARED WITH THAT OFBROMOCRIPTINE IN AN OPEN-LABEL, CROSSOVER STUDY
Authors: BOAS J WORMPETERSEN J DUPONT E MIKKELSEN B WERMUTH L
Citation: J. Boas et al., THE LEVODOPA DOSE-SPARING CAPACITY OF PERGOLIDE COMPARED WITH THAT OFBROMOCRIPTINE IN AN OPEN-LABEL, CROSSOVER STUDY, European journal of neurology, 3(1), 1996, pp. 44-49
THE LEVODOPA DOSE-SPARING CAPACITY OF PERGOLIDE COMPARED WITH THAT OFBROMOCRIPTINE
Authors: DUPONT E BOAS J MIKKELSEN B WERMUTH L WORMPETERSEN J
Citation: E. Dupont et al., THE LEVODOPA DOSE-SPARING CAPACITY OF PERGOLIDE COMPARED WITH THAT OFBROMOCRIPTINE, European journal of neurology, 3, 1996, pp. 9-12
SEXUAL PARTNERS OF SUBSTANCE-ABUSE CLIENTS - STRATEGIES FOR HIV AIDS PREVENTION/
Authors: WERMUTH L
Citation: L. Wermuth, SEXUAL PARTNERS OF SUBSTANCE-ABUSE CLIENTS - STRATEGIES FOR HIV AIDS PREVENTION/, Journal of substance abuse treatment, 13(6), 1996, pp. 505-509
COGNITIVE FUNCTION IN YOUNG PARKINSONIAN-PATIENTS - REPLY
Authors: WERMUTH L KNUDSEN L BOLDSEN J
Citation: L. Wermuth et al., COGNITIVE FUNCTION IN YOUNG PARKINSONIAN-PATIENTS - REPLY, Acta neurologica Scandinavica, 94(1), 1996, pp. 77-77
A STUDY OF COGNITIVE FUNCTIONS IN YOUNG PARKINSONIAN-PATIENTS
Authors: WERMUTH L KNUDSEN L BOLDSEN J
Citation: L. Wermuth et al., A STUDY OF COGNITIVE FUNCTIONS IN YOUNG PARKINSONIAN-PATIENTS, Acta neurologica Scandinavica, 93(1), 1996, pp. 21-24
MORTALITY IN PATIENTS WITH PARKINSONS-DISEASE
Authors: WERMUTH L STENAGER EN STENAGER E BOLDSEN J
Citation: L. Wermuth et al., MORTALITY IN PATIENTS WITH PARKINSONS-DISEASE, Acta neurologica Scandinavica, 92(1), 1995, pp. 55-58
SEXUAL PROBLEMS IN YOUNG-PATIENTS WITH PARKINSONS-DISEASE
Authors: WERMUTH L STENAGER E
Citation: L. Wermuth et E. Stenager, SEXUAL PROBLEMS IN YOUNG-PATIENTS WITH PARKINSONS-DISEASE, Acta neurologica Scandinavica, 91(6), 1995, pp. 453-455
LEVODOPA USE IN DENMARK - HIGH-LEVELS IN GREENLAND AND THE FAROE ISLANDS
Authors: DEPEDROCUESTA J WERMUTH L ABRAIRA V STAWIARZ L
Citation: J. Depedrocuesta et al., LEVODOPA USE IN DENMARK - HIGH-LEVELS IN GREENLAND AND THE FAROE ISLANDS, Acta neurologica Scandinavica, 91(2), 1995, pp. 89-97
SUICIDE IN PATIENTS WITH PARKINSONS-DISEASE - AN EPIDEMIOLOGIC-STUDY
Authors: STENAGER EN WERMUTH L STENAGER E BOLDSEN J
Citation: En. Stenager et al., SUICIDE IN PATIENTS WITH PARKINSONS-DISEASE - AN EPIDEMIOLOGIC-STUDY, Acta psychiatrica Scandinavica, 90(1), 1994, pp. 70-72
Risultati: 1-16 |